​

Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?

OverviewForecastFinancialsChartTranscripts

Outlook Therapeutics Ownership Summary

Outlook Therapeutics is owned by 1.94% institutional investors, 35.58% insiders, and 62.48% retail investors. Rosalind advisors is the largest institutional shareholder, holding 3.15% of OTLK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.87% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOutlook Therapeutics1.94%35.58%62.48%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rosalind advisors450.00K3.15%$3.32M
Cwm---
Armstrong advisory group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rosalind advisors450.00K2.56%$3.32M
Cwm---
Armstrong advisory group---

Top Buyers

HolderShares% AssetsChange
Rosalind advisors450.00K2.56%138.22K
Cwm---283.00
Armstrong advisory group---3.58K

Top Sellers

HolderShares% AssetsChange
Armstrong advisory group---3.58K
Cwm---283.00
Rosalind advisors450.00K2.56%138.22K

Sold Out

HolderChange
Cwm-283.00
Armstrong advisory group-3.58K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241-450,000-119.48%--100.00%--
Jun 30, 20241-66.67%450,00042.57%353.60%1---100.00%
Mar 31, 20243-96.43%315,638-98.93%21.88%1-97.62%1-92.86%
Dec 31, 2023849.09%29,590,2448.54%1110.09%4213.51%14-22.22%
Sep 30, 202377-8.33%27,261,889-6.40%108.24%37-13.95%18-5.26%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv442.51K1.87%-
iShares Russell 2000 ETF369.41K1.56%-826.00
Vanguard Institutional Extnd Mkt Idx Tr281.28K1.19%-
iShares Russell 2000 Growth ETF103.67K0.44%-
CREF Stock R1100.34K0.42%65.13K
Federated Hermes MDT Small Cap Growth IS88.30K0.37%88.30K
Federated Hermes MDT SCG Institutional88.30K0.37%88.30K
Fidelity Extended Market Index85.03K0.36%-12.70K
Fidelity Small Cap Index79.46K0.34%-1.60K
State St Russell Sm/Mid Cp® Indx NL Cl C72.90K0.31%-3.10K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 26, 2024KENYON LAWRENCE A Chief Financial OfficerBuy$28.45K
Apr 15, 2024Syntone Ventures LLC-Buy$8.25M
Apr 15, 2024Syntone Ventures LLC-Buy$5.00M
Mar 28, 2024Haddadin Yezan Munther-Buy$22.24K
Mar 07, 2024Evanson Jeff CHIEF COMMERCIAL OFFICERBuy$26.24K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q31-
2024 Q22-
2024 Q12-
2023 Q4--

OTLK Ownership FAQ

Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 1.94%, followed by 35.58% insiders and 62.48% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 47.04%, which Outlook Therapeutics falls below.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Rosalind advisors is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.56% of its assets in 450K Outlook Therapeutics shares, valued at 3.32M$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Outlook Therapeutics shares, with 1.87% of its total shares outstanding invested in 442.51K Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools